Our group and others have previously demonstrated that small molecule inhibitors of MEK abrogate both constitutive and cytokine-stimulated p-ERK-mediated MM cell proliferation [7, 12–16, 35, 38, 39]. The gene discussed is MAP2K7; the disease is Miyoshi myopathy.